Skip to main content


Featured Article
The FDA has issued a Class II recall for a prescription treatment used for patients with severe acne.
A Class III recall is active for a prescription medication used to treat severe acne.


Nana Duffy, MD, dermatologist, Rochester Regional Health, explains the importance of ensuring patients understand how to use telehealth properly and to its full capacity.
Alice B. Gottlieb, MD, PhD, clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses the importance of early identification for patients with psoriatic arthritis as well as treatments that are currently…
Jean Liew, MD, senior fellow in the Division of Rheumatology at the University of Washington, discusses the health care burden patients with both cardiovascular disease and psoriatic arthritis experience and explains why the development of more…
Alan Menter, MD, chairman of the division of dermatology at Baylor University Medical Center, Dallas, TX, and Craig A. Elmets, MD, professor of dermatology at the University of Alabama in Birmingham and co-chair of the guideline workgroup, provide a…
Back to Top